.png)
Transcriptomics Market by Technology, Product & Services and End User - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 160 Category: Next Generation Technology Report Code : IC053517
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Transcriptomics Market by Technology (Microarray, Real Time-PCR (qPCR), Sequencing) Product & Services (Instruments, Consumables, Software, Services) End User (Pharmaceutical & Biotechnology Companies, Government Institutes & Academic Centers, Contract research Organizations (CROs)) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Transcriptomics Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Transcriptomics is the investigation of whole arrangement of RNA transcripts created by the genome of any living being. Developing progressions in the field of transcriptomics, for example, broad utilization of RNA-sequencing and ascend in use of transcriptomics, which incorporates medicate revelation is anticipated to drive the development of the transcriptomics market.
Drivers and Restraints
Increment in mechanical progressions and ascend in research allows by different foundations is anticipated to drive the market development. Moreover, the capability of RNAs to go about as contender for analytic biomarkers and indicators of medication reaction are foreseen to additionally drive the interest for transcriptomics all inclusive. Nonetheless, institutionalization worries over RNA sequencing and absence of talented experts confine the market development.
Regional Insights
North America represented the share of over % of the general market in 2017 and is anticipated to keep up its predominance all through the conjecture time frame.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Merck & Co., Inc.
- QIAGEN (Exiqon)
- Promega Corporation
- Fluidigm Corporation
- GE Healthcare Dharmacon Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Transcriptomics Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Instruments
o Consumables
o Software
o Services
· Transcriptomics Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Microarray
o Real Time-PCR (qPCR)
o Sequencing
· Transcriptomics Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Contract research Organizations (CROs)
o Government Institutes & Academic Centers
o Pharmaceutical & Biotechnology Companies
· Transcriptomics Market, By Key Players
o Thermo Fisher Scientific Inc.
o QIAGEN
o Bio-Rad Laboratories, Inc.,
o GE Healthcare Dharmacon Inc.
o Illumina, Inc.
o Agilent Technologies
o F. Hoffmann-La Roche Ltd
o Promega Corporation
o Merck & Co., Inc.
o Fluidigm Corporation
· Transcriptomics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Transcriptomics Market, By Country
o U.S. Transcriptomics Market
o Canada Transcriptomics Market
o Mexico Transcriptomics Market
o Europe
§ Europe Transcriptomics Market, By Country
o Germany Transcriptomics Market
o UK Transcriptomics Market
o France Transcriptomics Market
o Russia Transcriptomics Market
o Italy Transcriptomics Market
o Rest of Europe Transcriptomics Market
o Asia-Pacific
§ Asia-Pacific Transcriptomics Market, By Country
o China Transcriptomics Market
o Japan Transcriptomics Market
o South Korea Transcriptomics Market
o India Transcriptomics Market
o Southeast Asia Transcriptomics Market
o Rest of Asia-Pacific Transcriptomics Market
o South America
§ South America Transcriptomics Market
o Brazil Transcriptomics Market
o Argentina Transcriptomics Market
o Columbia Transcriptomics Market
o Rest of South America Transcriptomics Market
o Middle East and Africa
§ Middle East and Africa Transcriptomics Market
o Saudi Arabia Transcriptomics Market
o UAE Transcriptomics Market
o Egypt Transcriptomics Market
o Nigeria Transcriptomics Market
o South Africa Transcriptomics Market
o Rest of MEA Transcriptomics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Transcriptomics Market, By Product
5.1. Introduction
5.2. Global Transcriptomics Revenue and Market Share by Product (2017-2027)
5.2.1. Global Transcriptomics Revenue and Revenue Share by Product (2017-2027)
5.3. Instruments
5.3.1. Global Instruments Revenue and Growth Rate (2017-2027)
5.4. Consumables
5.4.1. Global Consumables Revenue and Growth Rate (2017-2027)
5.5. Software
5.5.1. Global Software Revenue and Growth Rate (2017-2027)
5.6. Services
5.6.1. Global Services Revenue and Growth Rate (2017-2027)
6. Transcriptomics Market, By Technology
6.1. Introduction
6.2. Global Transcriptomics Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Transcriptomics Revenue and Revenue Share by Technology (2017-2027)
6.3. Microarray
6.3.1. Global Microarray Revenue and Growth Rate (2017-2027)
6.4. Real Time-PCR (qPCR)
6.4.1. Global Real Time-PCR (qPCR) Revenue and Growth Rate (2017-2027)
6.5. Sequencing
6.5.1. Global Sequencing Revenue and Growth Rate (2017-2027)
7. Transcriptomics Market, By End User
7.1. Introduction
7.2. Global Transcriptomics Revenue and Market Share by End User (2017-2027)
7.2.1. Global Transcriptomics Revenue and Revenue Share by End User (2017-2027)
7.3. Contract research Organizations (CROs)
7.3.1. Global Contract research Organizations (CROs) Revenue and Growth Rate (2017-2027)
7.4. Government Institutes & Academic Centers
7.4.1. Global Government Institutes & Academic Centers Revenue and Growth Rate (2017-2027)
7.5. Pharmaceutical & Biotechnology Companies
7.5.1. Global Pharmaceutical & Biotechnology Companies Revenue and Growth Rate (2017-2027)
8. Transcriptomics Market, By Region
8.1. Introduction
8.2. Global Transcriptomics Revenue and Market Share by Regions
8.2.1. Global Transcriptomics Revenue by Regions (2017-2027)
8.3. North America Transcriptomics by Countries
8.3.1. North America Transcriptomics Revenue and Growth Rate (2017-2027)
8.3.2. North America Transcriptomics Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Transcriptomics by Countries
8.4.1. Europe Transcriptomics Revenue and Growth Rate (2017-2027)
8.4.2. Europe Transcriptomics Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Transcriptomics by Countries
8.5.1. Asia-Pacific Transcriptomics Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Transcriptomics Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Transcriptomics by Countries
8.6.1. South America Transcriptomics Revenue and Growth Rate (2017-2027)
8.6.2. South America Transcriptomics Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Transcriptomics by Countries
8.7.1. Middle East and Africa Transcriptomics Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Transcriptomics Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Thermo Fisher Scientific Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. QIAGEN
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Bio-Rad Laboratories, Inc.,
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. GE Healthcare Dharmacon Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Illumina, Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Agilent Technologies
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. F. Hoffmann-La Roche Ltd
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Promega Corporation
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Merck & Co., Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Fluidigm Corporation
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Transcriptomics Market Competition, by Manufacturer
10.1. Global Transcriptomics Financial Overview by Manufacturer (2017-2017)
10.2. Global Transcriptomics Price By Region (2017-2017)
10.3. Top 5 Transcriptomics Manufacturer Market Share
10.4. Market Competition Trend
11. Transcriptomics Market Forecast (2017-2027)
11.1. Global Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Transcriptomics Market Forecast by Regions (2017-2027)
11.2.1. North America Transcriptomics Market Forecast (2017-2027)
11.2.1.1. United States Transcriptomics Market Forecast (2017-2027)
11.2.1.2. Canada Transcriptomics Market Forecast (2017-2027)
11.2.1.3. Mexico Transcriptomics Market Forecast (2017-2027)
11.2.2. Europe Transcriptomics Market Forecast (2017-2027)
11.2.2.1. Germany Transcriptomics Market Forecast (2017-2027)
11.2.2.2. France Transcriptomics Market Forecast (2017-2027)
11.2.2.3. UK Transcriptomics Market Forecast (2017-2027)
11.2.2.4. Russia Transcriptomics Market Forecast (2017-2027)
11.2.2.5. Italy Transcriptomics Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Transcriptomics Market Forecast (2017-2027)
11.2.3. Asia-Pacific Transcriptomics Market Forecast (2017-2027)
11.2.3.1. China Transcriptomics Market Forecast (2017-2027)
11.2.3.2. Japan Transcriptomics Market Forecast (2017-2027)
11.2.3.3. Korea Transcriptomics Market Forecast (2017-2027)
11.2.3.4. India Transcriptomics Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Transcriptomics Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Transcriptomics Market Forecast (2017-2027)
11.2.4. South America Transcriptomics Market Forecast (2017-2027)
11.2.4.1. Brazil Transcriptomics Market Forecast (2017-2027)
11.2.4.2. Argentina Transcriptomics Market Forecast (2017-2027)
11.2.4.3. Columbia Transcriptomics Market Forecast (2017-2027)
11.2.4.4. Rest of South America Transcriptomics Market Forecast (2017-2027)
11.2.5. Middle East and Africa Transcriptomics Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Transcriptomics Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Transcriptomics Market Forecast (2017-2027)
11.2.5.3. Egypt Transcriptomics Market Forecast (2017-2027)
11.2.5.4. Nigeria Transcriptomics Market Forecast (2017-2027)
11.2.5.5. South Africa Transcriptomics Market Forecast (2017-2027)
11.2.5.6. Turkey Transcriptomics Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Transcriptomics Market Forecast (2017-2027)
11.3. Transcriptomics Market Forecast by Product (2017-2027)
11.3.1. Transcriptomics Forecast by Product (2017-2027)
11.3.2. Transcriptomics Market Share Forecast by Product (2017-2027)
11.4. Transcriptomics Market Forecast by Technology (2017-2027)
11.4.1. Transcriptomics Forecast by Technology (2017-2027)
11.4.2. Transcriptomics Market Share Forecast by Technology (2017-2027)
11.5. Transcriptomics Market Forecast by End User (2017-2027)
11.5.1. Transcriptomics Forecast by End User (2017-2027)
11.5.2. Transcriptomics Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Transcriptomics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Transcriptomics Revenue and Revenue Share by Product (2017-2018)
Figure Global Instruments Revenue and Growth Rate (2017-2018)
Figure Global Consumables Revenue and Growth Rate (2017-2018)
Figure Global Software Revenue and Growth Rate (2017-2018)
Figure Global Services Revenue and Growth Rate (2017-2018)
Table Global Transcriptomics Revenue and Revenue Share by Technology (2017-2018)
Figure Global Microarray Revenue and Growth Rate (2017-2018)
Figure Global Real Time-PCR (qPCR) Revenue and Growth Rate (2017-2018)
Figure Global Sequencing Revenue and Growth Rate (2017-2018)
Table Global Transcriptomics Revenue and Revenue Share by End User (2017-2018)
Figure Global Contract research Organizations (CROs) Revenue and Growth Rate (2017-2018)
Figure Global Government Institutes & Academic Centers Revenue and Growth Rate (2017-2018)
Figure Global Pharmaceutical & Biotechnology Companies Revenue and Growth Rate (2017-2018)
Table Global Transcriptomics Revenue by Regions (2017-2018)
Figure North America Transcriptomics Growth Rate (2017-2018)
Figure North America Transcriptomics Revenue and Growth Rate (2017-2018)
Figure North America Transcriptomics by Countries (2017-2018)
Figure North America Transcriptomics Revenue (Million USD) by Countries (2017-2018)
Figure United States Transcriptomics Growth Rate (2017-2018)
Figure United States Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Transcriptomics Growth Rate (2017-2018)
Figure Canada Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Transcriptomics Growth Rate (2017-2018)
Figure Mexico Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Transcriptomics Growth Rate (2017-2018)
Figure Europe Transcriptomics Revenue and Growth Rate (2017-2018)
Figure Europe Transcriptomics by Countries (2017-2018)
Figure Europe Transcriptomics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Transcriptomics Growth Rate (2017-2018)
Figure Germany Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Transcriptomics Growth Rate (2017-2018)
Figure France Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Transcriptomics Growth Rate (2017-2018)
Figure UK Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Transcriptomics Growth Rate (2017-2018)
Figure Russia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Transcriptomics Growth Rate (2017-2018)
Figure Italy Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Transcriptomics Growth Rate (2017-2018)
Figure Rest of Europe Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Transcriptomics Growth Rate (2017-2018)
Figure Asia-Pacific Transcriptomics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Transcriptomics by Countries (2017-2018)
Figure Asia-Pacific Transcriptomics Revenue (Million USD) by Countries (2017-2018)
Figure China Transcriptomics Growth Rate (2017-2018)
Figure China Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Transcriptomics Growth Rate (2017-2018)
Figure Japan Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Transcriptomics Growth Rate (2017-2018)
Figure Korea Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Transcriptomics Growth Rate (2017-2018)
Figure India Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Transcriptomics Growth Rate (2017-2018)
Figure Southeast Asia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Transcriptomics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Transcriptomics Growth Rate (2017-2018)
Figure South America Transcriptomics Revenue and Growth Rate (2017-2018)
Figure South America Transcriptomics by Countries (2017-2018)
Figure South America Transcriptomics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Transcriptomics Growth Rate (2017-2018)
Figure Brazil Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Transcriptomics Growth Rate (2017-2018)
Figure Argentina Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Transcriptomics Growth Rate (2017-2018)
Figure Columbia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Transcriptomics Growth Rate (2017-2018)
Figure Rest of South America Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Transcriptomics Growth Rate (2017-2018)
Figure Middle East and Africa Transcriptomics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Transcriptomics by Countries (2017-2018)
Figure Middle East and Africa Transcriptomics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Transcriptomics Growth Rate (2017-2018)
Figure Saudi Arabia Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Transcriptomics Growth Rate (2017-2018)
Figure United Arab Emirates Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Transcriptomics Growth Rate (2017-2018)
Figure Egypt Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Transcriptomics Growth Rate (2017-2018)
Figure Nigeria Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Transcriptomics Growth Rate (2017-2018)
Figure South Africa Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Transcriptomics Growth Rate (2017-2018)
Figure Turkey Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Transcriptomics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Transcriptomics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Thermo Fisher Scientific Inc. Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table QIAGEN Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bio-Rad Laboratories, Inc., Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GE Healthcare Dharmacon Inc. Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina, Inc. Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Agilent Technologies Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche Ltd Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Promega Corporation Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co., Inc. Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fluidigm Corporation Transcriptomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Transcriptomics Market Share by Manufacturer
Figure Global Transcriptomics Revenue and Market Share by Manufacturer
Table Global Transcriptomics Price by Region (2017-2017)
Figure Top 5 Transcriptomics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Transcriptomics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Transcriptomics Market Forecast by Regions (2018-2025)
Figure North America Transcriptomics Market Forecast (2018-2025)
Figure United States Transcriptomics Market Forecast (2018-2025)
Figure Canada Transcriptomics Market Forecast (2018-2025)
Figure Mexico Transcriptomics Market Forecast (2018-2025)
Figure Europe Transcriptomics Market Forecast (2018-2025)
Figure Germany Transcriptomics Market Forecast (2018-2025)
Figure France Transcriptomics Market Forecast (2018-2025)
Figure UK Transcriptomics Market Forecast (2018-2025)
Figure Russia Transcriptomics Market Forecast (2018-2025)
Figure Italy Transcriptomics Market Forecast (2018-2025)
Figure Rest of Europe Transcriptomics Market Forecast (2018-2025)
Figure Asia-Pacific Transcriptomics Market Forecast (2018-2025)
Figure China Transcriptomics Market Forecast (2018-2025)
Figure Japan Transcriptomics Market Forecast (2018-2025)
Figure Korea Transcriptomics Market Forecast (2018-2025)
Figure India Transcriptomics Market Forecast (2018-2025)
Figure Southeast Asia Transcriptomics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Transcriptomics Market Forecast (2018-2025)
Figure South America Transcriptomics Market Forecast (2018-2025)
Figure Brazil Transcriptomics Market Forecast (2018-2025)
Figure Argentina Transcriptomics Market Forecast (2018-2025)
Figure Columbia Transcriptomics Market Forecast (2018-2025)
Figure Rest of South America Transcriptomics Market Forecast (2018-2025)
Figure Middle East and Africa Transcriptomics Market Forecast (2018-2025)
Figure Saudi Arabia Transcriptomics Market Forecast (2018-2025)
Figure United Arab Emirates Transcriptomics Market Forecast (2018-2025)
Figure Egypt Transcriptomics Market Forecast (2018-2025)
Figure Nigeria Transcriptomics Market Forecast (2018-2025)
Figure South Africa Transcriptomics Market Forecast (2018-2025)
Figure Turkey Transcriptomics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Transcriptomics Market Forecast (2018-2025)
Figure Global Transcriptomics Forecast by Product (2018-2025)
Figure Global Transcriptomics Market Share Forecast by Product (2018-2025)
Figure Global Transcriptomics Forecast by Product (2018-2025)
Figure Global Transcriptomics Forecast by Technology (2018-2025)
Figure Global Transcriptomics Market Share Forecast by Technology (2018-2025)
Figure Global Transcriptomics Forecast by Technology (2018-2025)
Figure Global Transcriptomics Forecast by End User (2018-2025)
Figure Global Transcriptomics Market Share Forecast by End User (2018-2025)
Figure Global Transcriptomics Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|